Our group is devoted to developing novel biotherapeutics that interact with the disease microenvironment to precisely target and modulate the progression of diseases. With an understanding of nanotechnology, biotechnology, and medical science, we aim to develop engineered biopolymers, living biotherapeutics, and extracellular vesicles to develop translational medicine for cancer immunotherapy, regenerative therapy, and reprogramming of microbiomes.
Research interest
우리 연구실에서는 나노기술, 생명공학, 의학의 융합을 통해 더욱 효과적으로 질병을 치료할 수 있는 나노의학(nanomedicine) 기술에 대하여 연구하고 있습니다. 분자 수준의 정밀한 표적 치료 기술을 활용한 난치성 질환의 치료, 그리고 유전자 제어를 통한 항노화 치료에 대해 관심이 있는 연구팀이나 학생 분들은 주저 없이 저희 연구실의 문을 두드려주세요.
Developing disease-targeted therapeutics or innovative new drugs using novel mechanisms using various materials incorporating nanotechnology.
Developing advanced biopharmaceuticals by using various engineering technologies to maximize the therapeutic potential of exosomes.
Developing new biopharmaceuticals by incorporating nanotechnology to make microbes more useful in treating disease.
Lab member’s News